Analytical Data
-
Gene name
TNS1
- Application
-
Alternative Names
TNS; MXRA6; Matrix-Remodelling Associated 6
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HBL0
-
Expression Region
Ser4~Gly307
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNS1, or Tensin 1, is an important cytoskeletal protein that plays a pivotal role in cellular adhesion, migration, and signaling processes. As a member of the tensin family, TNS1 is known to interact with focal adhesions, serving as a link between integrins and the actin cytoskeleton. Recent studies have highlighted its involvement in various biological processes, including cell proliferation and differentiation, and its implications in cancer metastasis and progression. Given its crucial functions, there is a growing interest in understanding TNS1 at the molecular level, particularly through the study of recombinant TNS1 proteins. Research in this area aims to elucidate the structure-function relationships of TNS1, its binding interactions with other cellular proteins, and its regulatory mechanisms. Additionally, recombinant TNS1 can be utilized as a tool for drug development and therapeutic interventions targeting diseases associated with dysregulated cellular adhesion and migration. Through advanced recombinant techniques, researchers can produce TNS1 in various forms to facilitate in vitro assays, structural biology studies, and potential therapeutic applications, thereby contributing to a deeper understanding of its roles in health and disease.
